- Home
- / Inivata
Inivata
Total Funding
$129.4 M
Revenue
£128.2 K
FY, 2018
Inivata Summary
Company Summary
- Overview
- Inivata is a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The Company offers a tagged-amplicon sequencing method, that allows amplification and deep sequencing of genomic regions spanning thousands of bases from individual copies of fragmented DNA.
- Type
- Private
- Status
- Active
- Founded
- 2014
- HQ
- Great Abington, GB | view all locations
- Website
- http://www.inivata.com/
- Cybersecurity rating
Table of Contents
Key People
Robert Tansley, Non-Executive Director
Tim Shannon, Chief Financial Officer
Peter Collins, Chief Business Officer
LocationsView all
3 locations detected
Great Abington HQ
United Kingdom
Granta Park
Morrisville, NC
United States
7020 Kit Creek Rd #140
Babraham, England
United Kingdom
Babraham Hall
Inivata Financials
Summary Financials
- Revenue (FY, 2018)
- £128.2K
- Gross profit (FY, 2018)
- £31.2K
- Net income (FY, 2018)
- (£16.7M)
- Cash (FY, 2018)
- £6.9M
- EBIT (FY, 2018)
- (£19.8M)